News
Important Only
Stocks
Long‑Term Care Planning for Early Retirees
Most people who are planning for early retirement are focused on making sure they have a big nest egg so they can enjoy traveling or spending more time with loved ones without worrying about running short of funds.While you absolutely want to save for your dream retirement and ensure you can afford ...The Motley Fool
Sat, May 31
Other
Philippines defence chief says China needs to overcome 'deficit of trust'
Teodoro criticises China's reliance on propaganda in defense talksASEAN neighbours less vocal than Philippines on China's sea claimsChina accuses U.S. of causing regional discordBy Rae Wee and Greg Torode SINGAPORE, May 31 (Reuters) - China has a "deficit of trust and credibility"...Reuters
Sat, May 31
Cryptocurrencies
EU promises countermeasures in criticism of US steel tariff hike
The EU is calling out the White House after President Donald Trump said on Friday that he’s hiking steel and aluminum tariffs to 50%, up from the current 25%. According to Reuters, the European Commission responded just a day later, calling the decision reckless and warning that countermeasures are already in the works. Officials in […]Cryptopolitan
Sat, May 31
Cryptocurrencies
More Crypto Clarity: US SEC Says Most Staking Activities Are Not Securities
In a significant development for the industry, the US Securities and Exchange Commission’s (SEC) Division of Corporation Finance shared its view on crypto staking after the recent call for clear guidance on the sector. The SEC branch seeks to “provide greater clarity on the application of the federa...Bitcoinist
Sat, May 31
Other
Tempus Introduces Fuses, A Program Designed To Transform Therapeutic Research And Build The Largest Diagnostic Platform Using Its Novel Foundation Model
May 31 (Reuters) - Tempus AI Inc TEM.O:TEMPUS INTRODUCES FUSES, A PROGRAM DESIGNED TO TRANSFORM THERAPEUTIC RESEARCH AND BUILD THE LARGEST DIAGNOSTIC PLATFORM USING ITS NOVEL FOUNDATION MODELReuters
Sat, May 31
Cryptocurrencies
SEC forwards plan to freeze budget and trim staff headcount
The SEC is cutting back on staff and locking in its budget for next year. On Friday night, the agency said it’s asking Congress to keep its 2026 funding flat at $2.15 billion, the same amount it received for 2025. Along with the frozen budget, the regulator wants to slash its full-time headcount by nearly […]Cryptopolitan
Sat, May 31
Other
Arvinas And Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival For Patients With Esr1-Mutant, Er+/Her2- Advanced Breast Cancer
May 31 (Reuters) - Arvinas Inc ARVN.O:ARVINAS AND PFIZER'S VEPDEGESTRANT SIGNIFICANTLY IMPROVES PROGRESSION-FREE SURVIVAL FOR PATIENTS WITH ESR1-MUTANT, ER+/HER2- ADVANCED BREAST CANCERARVINAS INC - VEPDEGESTRANT WELL TOLERATED WITH LOW GI ADVERSE EVENTSARVINAS INC - VEPDEGESTRANT FIRST PROTAC T...Reuters
Sat, May 31
Stocks
3 Reasons This Artificial Intelligence Stock Could Have the Biggest Comeback in 2025
Following a dismal start to the year for The Trade Desk (NASDAQ: TTD), shareholders are hoping the second half of 2025 reprograms the narrative. The stock is down 47% from its 52-week-high amid the broader market turbulence, even as the advertising technology (adtech) pioneer continues to generate i...The Motley Fool
Sat, May 31
Other
Regeneron Pharmaceuticals Inc Says Libtayo Shows 68% Reduction In Risk Of Disease Recurrence Or Death
May 31 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:REGENERON PHARMACEUTICALS INC - LIBTAYO SHOWS 68% REDUCTION IN RISK OF DISEASE RECURRENCE OR DEATHREGENERON PHARMACEUTICALS INC - LIBTAYO SHOWS 80% REDUCTION IN LOCOREGIONAL RECURRENCE RISKREGENERON PHARMACEUTICALS INC - LIBTAYO SHOWS 65% REDUC...Reuters
Sat, May 31
Other
Novocure Says Ttfields Therapy Shows Significant Improvement In Overall Survival For Pancreatic Cancer
May 31 (Reuters) - Novocure Ltd NVCR.O:RESULTS FROM THE PHASE 3 PANOVA-3 TRIAL OF NOVOCURE’S TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PANCREATIC CANCER TO BE PRESENTED AT 2025 ASCO ANNUAL MEETINGNOVOCURE LTD - TTFIELDS THERAPY SHOWS SIGNIFICANT IMPROVEMENT IN OVERALL SURVIVAL FOR PANCREATIC CANC...Reuters
Sat, May 31
Other
Xilio Therapeutics Announces Updated Phase 2 Data For Vilastobart, A Tumor-Activated Anti-Ctla-4, In Combination With Atezolizumab In Patients With Metastatic Microsatellite Stable Colorectal Cancer
May 31 (Reuters) - Xilio Therapeutics Inc XLO.O:XILIO THERAPEUTICS ANNOUNCES UPDATED PHASE 2 DATA FOR VILASTOBART, A TUMOR-ACTIVATED ANTI-CTLA-4, IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH METASTATIC MICROSATELLITE STABLE COLORECTAL CANCERXILIO THERAPEUTICS INC - 26% RESPONSE RATE IN METASTAT...Reuters
Sat, May 31
Other
Merck Says Keytruda® Plus Trodelvy® Reduced Risk Of Disease Progression Or Death By 35% Versus Keytruda Plus Chemotherapy In First-Line Pd-L1+ Metastatic Triple-Negative Breast Cancer
May 31 (Reuters) - Merck MRK.N: KEYTRUDA® (PEMBROLIZUMAB) PLUS TRODELVY® (SACITUZUMAB GOVITECAN-HZIY) REDUCED RISK OF DISEASE PROGRESSION OR DEATH BY 35% VERSUS KEYTRUDA PLUS CHEMOTHERAPY IN FIRST-LINE PD-L1+ METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC)MERCK & CO INC - KEYTRUDA PLUS TRODELVY ...Reuters
Sat, May 31
Stocks
This Is the Average Social Security Benefit for Early Claimers
Social Security benefits can be claimed between the ages of 62 and 70. However, every retiree has been given a full retirement age (FRA) based on their birth year. FRA is the age you get your standard benefit. Claiming anytime before FRA will shrink that standard check amount, leaving retired worker...The Motley Fool
Sat, May 31
Stocks
3 Magnificent Dividend Stocks Down 15% to 64% to Buy and Hold for 20 Years
This is a great time to consider adding quality dividend stocks to your investment portfolio. Recent headwinds in the economy have weighed on sales of leading retail and consumer goods brands, and this has driven their stocks down and their yields higher.While the near term could be rocky, investors...The Motley Fool
Sat, May 31
Other
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
Trodelvy/Keytruda patients had 11.2 months progression-free survival vs 7.8 months for chemotherapy/Keytruda ASCO says Trodelvy/Keytruda likely to become standard of carePatients still being followed to see if combination extends survivalBy Deena Beasley May 31 (Reuters) - Gilead Sciences' GI...Reuters
Sat, May 31
Commodities
EU Commission 'strongly' regrets announced increase in US steel tariffs
BRUSSELS, May 31 (Reuters) - The European Commission said on Saturday that it "strongly" regrets an announced increase in U.S. tariffs on steel imports. U.S. President Donald Trump said on Friday he planned to increase tariffs on imported steel and aluminum to 50% from 25%, putting more...Reuters
Sat, May 31
Other
Israel says after IAEA report, the international community must stop Iran
JERUSALEM, May 31 (Reuters) - Israel said on Saturday that the latest report from the International Atomic Energy Agency showed that Iran's nuclear programme was not peaceful and that Tehran remained determined to complete its nuclear weapons programme."The international community must act n...Reuters
Sat, May 31
Stocks
Does This Move Make Medtronic Stock a Buy?
Over the past few years, Medtronic (NYSE: MDT) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth, and economic issues that impacted its financial results. Throughout it all, Medtronic's diabetes care business has consistently been one of its fast...The Motley Fool
Sat, May 31
